News
Waystar, a healthcare payment technology company that went public last year, is pointing to generative artificial intelligence as a potential way for providers to save money on prior authorization ...
LEHI, Utah, and LOUISVILLE, Ky., April 23, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, will host an Innovation Showcase today at 2 p.m. ET.
Barclays analyst Saket Kalia maintained a Buy rating on Waystar Holding Corp. (WAY – Research Report) today and set a price target of $45.00. The company’s shares closed last Friday at $37.27.
LEHI, Utah – Waystar (WAY), a Nasdaq-listed healthcare payment software provider with a market capitalization of $6.1 billion, announced today the launch of new generative AI capabilities and ...
LEHI, Utah – Waystar (WAY), a Nasdaq-listed healthcare payment software provider with a market capitalization of $6.1 billion, announced today the launch of new generative AI capabilities and advanced ...
BofA analyst Allen Lutz lowered the firm’s price target on Waystar (WAY) to $48 from $51 and keeps a Buy rating on the shares. The firm’s Q1 survey indicates a slowdown in health systems ...
During the last three months, 6 analysts shared their evaluations of Waystar Holding WAY, revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their ...
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (WAY), a provider of leading healthcare payment software, announced today that it will report financial results ...
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial ...
In other Waystar news, insider T. Craig Bridge sold 182,914 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $42.15, for a ...
Barclays increased their target price on Waystar from $42.00 to $50.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results